ACCESSWIRE
20 Jan 2023, 03:43 GMT+10
NEW YORK, NY / ACCESSWIRE / January 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Karyopharm Therapeutics Inc. ('Karyopharm' or the 'Company') (NASDAQ:KPTI). Investors who purchased Karyopharm securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/kpti.
The investigation concerns whether Karyopharm has violated federal securities laws.
On February 8, 2022, Karyopharm reported 'successful'-though ultimately disappointing-results from its Phase 3 SIENDO Study of Xpovio for the treatment of endometrial cancer. Specifically, the treatment reduced patients' risk of disease progression or death by 30%, just barely enough to be considered statistically significant, and median progression-free survival was just 5.7 months compared to 3.8 months among patients randomized to receive a placebo. On this news, Karyopharm's stock price fell $2.05 per share, or 20.02%, to close at $8.19 per share on February 8, 2022.
Then, on March 1, 2022, Karyopharm reported negative feedback from the U.S. Food and Drug Administration ('FDA') on its supplemental NDA for Xpovio based on the Phase 3 SIENDO Study results for endometrial cancer. Specifically, the FDA found that the current results would not support NDA approval as Karyopharm and the FDA participants had differing views on the study's significance and overall clinical benefit for the whole population. On this news, Karyopharm's stock price fell $4.13 per share, or 39.75%, to close at $6.26 per share on March 2, 2022.
If you are aware of any facts relating to this investigation or purchasedKaryopharm shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/kpti. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
Get a daily dose of Tennessee Daily news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Tennessee Daily.
More InformationNEW DELHI, India: Marking a year since the Tata Group took control of Air India, the former state-run carrier has ...
NEW YORK, New York - A slowing of wages growth in the fourth quarter, as reported by the Labor Department, ...
NEW YORK CITY, New York: As it sets aside more funds to cover potentially bad loans, American Express announced that ...
LONDON, England: Flybe, a British regional airline, abruptly closed operations on January 28. The airline offered flight to Belfast, Birmingham ...
JERUSALEM, Israel: As demand for its driver-assistance technology rises among vehicle-makers, Mobileye Global is forecasting revenues for the 2023 fiscal ...
NEW YORK, New York - U.S. stocks closed sharply lower Monday as investors fretted over which way the Federal Reserve ...
NEW YORK CITY, New York: As it sets aside more funds to cover potentially bad loans, American Express announced that ...
MIAMI, Florida: This decade, the US south is expected to see more new residents than any other region in the ...
JERUSALEM, Israel: As demand for its driver-assistance technology rises among vehicle-makers, Mobileye Global is forecasting revenues for the 2023 fiscal ...
LONG BEACH, California: Long Beach, California-based Rocket Lab has launched its first mission from the United States, as part of ...
Israel was behind Sunday morning's drone strike on an Iranian munitions facility; the Wall Street Journal has reported, citing American ...
LONDON, England: Of the 14 main battle tanks and additional artillery support it will send to Ukraine, Britain hopes its ...